Shield Therapeutics Plc (STX.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 06-2020 | 12-2019 | 06-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,007 | 8,019 | 5,430 | 8,374 | 12,405 |
| Inventories | 1,879 | 1,705 | 1,243 | 574 | 138 |
| Other current assets | 894 | 2,086 | 1,504 | 3,745 | 2,490 |
| TOTAL | $7,128 | $11,810 | $8,385 | $12,693 | $15,755 |
| Non-Current Assets | |||||
| PPE Net | 44 | 6 | 34 | 137 | 10 |
| Intangibles | 37,159 | 35,254 | 39,201 | 38,917 | 39,282 |
| TOTAL | $37,202 | $35,260 | $39,235 | $39,054 | $39,292 |
| Total Assets | $44,330 | $47,070 | $47,620 | $51,747 | $55,046 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 538 | 2,856 | 3,496 | 2,372 | 28 |
| Other current liabilities | N/A | 559 | N/A | 150 | N/A |
| TOTAL | $3,069 | $3,414 | $5,473 | $2,651 | $3,745 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $3,069 | $3,414 | $5,473 | $2,651 | $3,745 |
| Shareholders' Equity | |||||
| Common Shares | 2,404 | 2,164 | 2,305 | 2,225 | 2,216 |
| Retained earnings | -120,271 | -102,214 | -113,274 | -101,110 | -99,036 |
| Other shareholders' equity | 38,719 | 34,955 | 37,273 | 36,014 | 36,029 |
| TOTAL | $41,261 | $43,656 | $42,147 | $49,096 | $51,302 |
| Total Liabilities And Equity | $44,330 | $47,070 | $47,620 | $51,747 | $55,046 |